Coherent Again Deems a II-VI Proposal Superior to Terms of a Lumentum Merger Agreement - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Coherent Again Deems a II-VI Proposal Superior to Terms of a Lumentum Merger Agreement

    Article obtained from Photonics RSS Feed.

    Coherent confirmed it has received a buyout offer from II-VI that the Coherent board deems “superior” to terms of an amended merger agreement between it and Lumentum. The company today said its board determined that the revised acquisition proposal from II-VI, which builds on a previous revised proposal from II-VI, constituted a “Company Superior Proposal.”

    Per terms of the latest proposal from II-VI, each share of Coherent common stock would be exchanged for $195 and one share of II-VI common stock at the completion of the transaction. Coherent said it once again has informed Lumentum it intends to terminate their amended merger agreement unless it receives a revised proposal from Lumentum by Wednesday, March…

    READ MORE
    Mar, 12 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.